18th April 2018

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis

How do SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors compare in reducing and events in patients with type 2 ? Find out by reading the below link to the article:

https://jamanetwork.com/journals/jama/fullarticle/2678616

 

Thousands of patients denied GP follow-up after asthma attack
Thousands of patients denied GP follow-up after asthma attack

12th February 2019

Read
COMMISSIONER WANTS PHARMACISTS INVOLVED
COMMISSIONER WANTS PHARMACISTS INVOLVED

25th January 2019

Read
NHS England update on recommended flu vaccines for 2019/20
NHS England update on recommended flu vaccines for 2019/20

24th January 2019

Read